Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenazopyridine for Voiding After Mid-urethral Sling
NCT02806713Phase 3Completed
- Sponsor
- University of Massachusetts
- Start
- Feb 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of phenazopyridine in Dysfunctional voiding (DV), postoperative pain, sponsored by University of Massachusetts. Started Feb 2016; status: completed.
02
Drugs
phenazopyridine
03
Conditions
Dysfunctional voiding (DV)postoperative pain
Beyond the preview
Go deeper on NCT02806713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806713.